SERUM C PEPTIDE LEVELS AND ITS ASSOCIATION WITH CHRONIC VASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Not Applicable
- Conditions
- Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
- Registration Number
- CTRI/2023/03/050714
- Lead Sponsor
- SELF
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Type 2 diabetes mellitus patients of both sex with ages more than 35 years with a duration of diabetes of more than 5 years and less than 15 years
Exclusion Criteria
1. Type 2 diabetic patients on insulin treatment
2. All patients with secondary diabetes and those on steroid therapy.
3. Pregnant and lactating females.
4. Patients with active infections like pneumonia, sepsis and critical illness.
5. Patients with chronic liver disease, acute hepatitis and malignancy.
6. Patients with renal impairment with GFR less than 45ml/min/1.73m2
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chronic Microvascular Complications- Diabetic Retinopathy, Diabetic Neuropathy and Diabetic Nephropathy. <br/ ><br>Chronic Macrovascular Complications- Coronary Artery disease,Cerebro vascular disease and Peripheral Artery diseaseTimepoint: At baseline.
- Secondary Outcome Measures
Name Time Method Chronic Macrovascular Complications- Coronary Artery disease,Cerebro vascular disease and Peripheral Artery diseaseTimepoint: At baseline itself.